UnitedHealth Group (NYSE:UNH - Get Free Report) had its target price increased by research analysts at Wells Fargo & Company from $267.00 to $400.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage presently has an "overweight" rating on the healthcare conglomerate's stock. Wells Fargo & Company's target price points to a potential upside of 11.48% from the stock's previous close.
Several other brokerages have also recently commented on UNH. UBS Group reissued a "buy" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Sanford C. Bernstein raised their price target on UnitedHealth Group from $337.00 to $379.00 and gave the company an "outperform" rating in a research note on Friday, September 5th. Robert W. Baird reiterated an "underperform" rating and issued a $198.00 price objective (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Weiss Ratings reiterated a "sell (d+)" rating on shares of UnitedHealth Group in a research note on Saturday, September 27th. Finally, KeyCorp reduced their price objective on shares of UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a research report on Wednesday, July 30th. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and four have issued a Sell rating to the stock. According to MarketBeat, UnitedHealth Group currently has an average rating of "Hold" and an average target price of $365.00.
Check Out Our Latest Stock Report on UnitedHealth Group
UnitedHealth Group Trading Up 0.0%
Shares of NYSE UNH traded up $0.05 during midday trading on Tuesday, reaching $358.82. 1,390,652 shares of the stock were exchanged, compared to its average volume of 12,731,018. The stock has a market capitalization of $324.97 billion, a P/E ratio of 15.54, a PEG ratio of 2.34 and a beta of 0.47. UnitedHealth Group has a twelve month low of $234.60 and a twelve month high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The company has a 50 day simple moving average of $309.38 and a 200 day simple moving average of $352.34.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. During the same quarter in the prior year, the company posted $6.80 earnings per share. The business's revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts expect that UnitedHealth Group will post 29.54 earnings per share for the current year.
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in the company. Brighton Jones LLC raised its position in shares of UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after buying an additional 28,231 shares during the period. Revolve Wealth Partners LLC increased its position in shares of UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after acquiring an additional 2,324 shares in the last quarter. Courier Capital LLC lifted its holdings in shares of UnitedHealth Group by 3.0% during the 1st quarter. Courier Capital LLC now owns 4,320 shares of the healthcare conglomerate's stock valued at $2,263,000 after acquiring an additional 127 shares in the last quarter. NewSquare Capital LLC lifted its stake in shares of UnitedHealth Group by 418.0% during the first quarter. NewSquare Capital LLC now owns 259 shares of the healthcare conglomerate's stock worth $136,000 after purchasing an additional 209 shares in the last quarter. Finally, Range Financial Group LLC grew its stake in shares of UnitedHealth Group by 12.6% in the first quarter. Range Financial Group LLC now owns 634 shares of the healthcare conglomerate's stock valued at $332,000 after buying an additional 71 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.
About UnitedHealth Group
(
Get Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.